The Society of Nuclear Medicine and Molecular Imaging (SNMMI) and IAC are pleased to recognize the first facilities to achieve Radiopharmaceutical Therapy accreditation:
Facilities honored include those that first achieved accreditation at least 20 years ago and currently hold IAC accreditation in 2026.
The Intersocietal Accreditation Commission (IAC) announces the appointment of Tanya K. Tolpegin, MBA, CAE as its new Chief Executive Officer (CEO), effective November 6, 2025.
Acknowledging the ongoing, rapid evolution of artificial intelligence (AI) in medicine, the IAC Board of Directors established an AI Task Force in 2024.
Facilities honored include those that first achieved accreditation at least 20 years ago and currently hold IAC accreditation in 2024.